Cloud-clone
SKU(재고 관리 코드):RPF709Hu01
Recombinant Peptidyl Arginine Deiminase Type IV (PADI4)
Recombinant Peptidyl Arginine Deiminase Type IV (PADI4)
Prokaryotic expression
Product No.
RPF709Hu01
Organism Species
Homo sapiens (Human).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Nucleus, Cytoplasm
Predicted Molecular Mass
36.3kDa
Accurate Molecular Mass
36kDa(Analysis of differences refer to the manual)
Residues & Tags
Met1~Pro300 with N-terminal His Tag
Buffer Formulation
100mMNaHCO3, 500mMNaCl, pH8.3, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
Traits
Freeze-dried powder
Purity
> 95%
Isoelectric Point
6.0
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Arthritis Res Ther. | Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility Pubmed:Pmc4229860 |
| Journal of Molecular Cell Biology | Peptidylarginine deiminase 4 concentration, but not polymorphisms, is associated with ICU mortality in septic shock patients Pubmed:30044533 |
| Journal of Inflammation Research | Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery Pubmed: 31213874 |
| Revista da Associacao Medica Brasileira | Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPF709Hu01 | Recombinant Peptidyl Arginine Deiminase Type IV (PADI4) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF709Hu01 | Polyclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu21 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB |
| MAF709Hu22 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu23 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu24 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| SEF709Hu | ELISA Kit for Peptidyl Arginine Deiminase Type IV (PADI4) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF709Hu | Magnetic Luminex Assay Kit for Peptidyl Arginine Deiminase Type IV (PADI4) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
